Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03476798
Title Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium
Acronym Clovis-001
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Oklahoma
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.